Inventor
SUN SHAOYI
CA49 patents
⚠️ This page may combine multiple inventors who share the name “SUN SHAOYI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XENON PHARMACEUTICALS INC
22 patentsUS7335658B2Feb 26, 2008
Pyridazine derivatives and their use as therapeutic agents
XENON PHARMACEUTICALS INC59 citations97
US8030488B2Oct 4, 2011
Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents
XENON PHARMACEUTICALS INC34 citations92
US7767677B2Aug 3, 2010
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
XENON PHARMACEUTICALS INC34 citations92
US7700641B2Apr 20, 2010
Spiro-oxindole compounds and their uses as therapeutic agents
XENON PHARMACEUTICALS INC39 citations92
US7592343B2Sep 22, 2009
Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors
XENON PHARMACEUTICALS INC22 citations92
US7456180B2Nov 25, 2008
Piperazine derivatives and their use as therapeutic agents
XENON PHARMACEUTICALS INC24 citations92
US9630929B2Apr 25, 2017
Benzenesulfonamide compounds and their use as therapeutic agents
XENON PHARMACEUTICALS INC11 citations84
US7547698B2Jun 16, 2009
Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)
XENON PHARMACEUTICALS INC18 citations84
US8916580B2Dec 23, 2014
Spiro-oxindole compounds and their use as therapeutic agents
XENON PHARMACEUTICALS INC4 citations83
US7919484B2Apr 5, 2011
Combination therapy
XENON PHARMACEUTICALS INC10 citations83
US9487535B2Nov 8, 2016
Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents
XENON PHARMACEUTICALS INC5 citations73
US7763618B2Jul 27, 2010
Pyridyl derivatives and their use as therapeutic agents
XENON PHARMACEUTICALS INC2 citations62
US7754711B2Jul 13, 2010
Pyridazine derivatives and their use as therapeutic agents
XENON PHARMACEUTICALS INC2 citations62
US11639351B2May 2, 2023
Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents
XENON PHARMACEUTICALS INC0 citations61
US10981905B2Apr 20, 2021
Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents
XENON PHARMACEUTICALS INC1 citations61
US9458178B2Oct 4, 2016
Spiro-oxindole compounds and their use as therapeutic agents
XENON PHARMACEUTICALS INC1 citations61
US8026360B2Sep 27, 2011
Substituted pyridazines as stearoyl-CoA desaturase inhibitors
XENON PHARMACEUTICALS INC3 citations61
US7919496B2Apr 5, 2011
Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes
XENON PHARMACEUTICALS INC1 citations52
US8383628B2Feb 26, 2013
Pyridyl derivatives and their use as therapeutic agents
XENON PHARMACEUTICALS INC0 citations51
US7605161B2Oct 20, 2009
Pyridyl derivatives and their use as therapeutic agents
XENON PHARMACEUTICALS INC0 citations51
US12054486B2Aug 6, 2024
Pyridine derivatives and their use as sodium channel activators
XENON PHARMACEUTICALS INC0 citations44
US7951805B2May 31, 2011
Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
XENON PHARMACEUTICALS INC0 citations41
GENENTECH INC
12 patentsUS8933236B2Jan 13, 2015
N-substituted benzamides and methods of use thereof
GENENTECH INC50 citations97
US8952169B2Feb 10, 2015
N-substituted benzamides and methods of use thereof
GENENTECH INC25 citations92
US9771376B2Sep 26, 2017
N-substituted benzamides and methods of use thereof
GENENTECH INC7 citations84
US9493429B2Nov 15, 2016
Substituted benzoxazoles and methods of use thereof
GENENTECH INC10 citations84
US10005724B2Jun 26, 2018
Therapeutic compounds and methods of use thereof
GENENTECH INC6 citations83
US9694002B2Jul 4, 2017
Substituted benzamides and methods of use thereof
GENENTECH INC11 citations83
US9546164B2Jan 17, 2017
Substituted benzamides and methods of use thereof
GENENTECH INC13 citations83
US10526285B2Jan 7, 2020
Therapeutic compounds and methods of use thereof
GENENTECH INC1 citations72
US10125098B2Nov 13, 2018
Therapeutic compounds and methods of use thereof
GENENTECH INC2 citations72
US9550775B2Jan 24, 2017
Substituted triazolopyridines and methods of use thereof
GENENTECH INC7 citations72
US11149002B2Oct 19, 2021
Therapeutic compounds and methods of use thereof
GENENTECH INC0 citations61
US10179767B2Jan 15, 2019
Substituted benzamides and methods of use thereof
GENENTECH INC0 citations51
DALES NATALIE
6 patentsUS8258160B2Sep 4, 2012
SCD1 inhibitors triazole and tetrazole compounds
DALES NATALIE11 citations82
US8063084B2Nov 22, 2011
Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid levels
DALES NATALIE6 citations72
US8501746B2Aug 6, 2013
Organic compounds
DALES NATALIE3 citations61
US9187426B2Nov 17, 2015
Organic compounds
DALES NATALIE0 citations51
US8293768B2Oct 23, 2012
Organic compounds
DALES NATALIE0 citations51
US8236835B2Aug 7, 2012
Heterocyclic inhibitors of stearoyl-CoA desaturase
DALES NATALIE0 citations41
CHAFEEV MIKHAIL
5 patentsUS8466188B2Jun 18, 2013
Use of spiro-oxindole compounds as therapeutic agents
CHAFEEV MIKHAIL63 citations97
US8106087B2Jan 31, 2012
Spiro-oxindole compounds and their uses as therapeutic agents
CHAFEEV MIKHAIL19 citations92
US8263606B2Sep 11, 2012
Spiro-oxindole compounds and their use as therapeutic agents
CHAFEEV MIKHAIL16 citations91
US8101647B2Jan 24, 2012
Spiro-oxindole compounds and their use as therapeutic agents
CHAFEEV MIKHAIL35 citations91
US8415370B2Apr 9, 2013
Spiro-oxindole compounds and their uses as therapeutic agents
CHAFEEV MIKHAIL10 citations82